Robert Coffin PhD

Robert Coffin is the Founder, President, and Chief Research & Development Officer of Replimune. Previously he was Founder & CTO of BioVex Inc, a spin-out from his research group at University College London in 1999. BioVex was acquired by Amgen in 2011 where Rob was VP of Global Development until 2013, before co-founding Replimune in 2015. Rob was awarded a Ph.D. in virology from Imperial College London prior to his move to University College London in 1991.